Market Intelligence chevron_right Medical Care chevron_right Hematologic Malignancies Detection
Global Report 2025

Global Hematologic Malignancies Detection Market Growth (Status and Outlook) 2025-2031

calendar_todayPublished: Jun 2025 descriptionPages: 115 categoryCategory: Medical Care
cloud_downloadRequest Sample Report
mailPre-Order Enquiry
local_offerGet Discount

The global Hematologic Malignancies Detection market size is predicted to grow from US$ 3207 million in 2025 to US$ 7474 million in 2031; it is expected to grow at a CAGR of 15.1% from 2025 to 2031.

Hematological malignancy is a major disease that seriously endangers human health. With the invention and application of polymerase chain reaction, immunohistochemistry, next-generation sequencing and fluorescence in situ hybridization, its overall diagnostic level has been significantly improved.

Increasing prevalence of hematological malignancies, emerging new technologies and methods for testing, patient preference for testing treatments, and increasing regulation across the healthcare industry are the key factors driving the growth of hematological malignancies testing market revenue.

Key Features

  • Latest research report on Hematologic Malignancies Detection Market.
  • Comprehensive analysis of past sales and projections.
  • Segmentation by region, market sector, and sub-sector.

Segmentation by Type

  • Polymerase Chain Reaction
  • Immunochemistry
  • Next Generation Sequencing
  • Fluorescence in Situ Hybridization
  • Others

Segmentation by Application

  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Leukemia
  • Myeloproliferative Neoplasms
  • Lymphoma
  • Others

Market by Region

  • Americas
  • APAC
  • Europe
  • Middle East & Africa

Company’s Coverage

  • ArcherDx
  • Bio-Rad Laboratories
  • sysmex
  • Invitae
  • NeoGenomics Laboratories
  • Abbott Laboratories
  • Cancer Genetics
  • Adaptive Biotechnologies Corporation
  • Asuragen
  • Invivoscribe
  • Nanjing Shihejiyin Technology
  • Annaroad Gene Technology
  • BGI Genomics

Key Questions Addressed in this Report

  • What is the market size of the Hematologic Malignancies Detection market?
  • What are the key drivers of market growth?
  • Which regions are expected to witness significant growth?

Frequently Asked Questions

What is the USP of the report? expand_more
Hematologic Malignancies Detection report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
What are the key content of the report? expand_more
Hematologic Malignancies Detection report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
What are the value propositions and opportunities offered in this market research report? expand_more
Hematologic Malignancies Detection report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.